(Q27853055)

13 November 2016

title

FGFR1 amplification is associated with poor prognosis and smoking in non-small-cell lung cancer. (English)

1 reference

PubMed publication ID

13 November 2016

1 reference

7

Kwhanmien Kim

0 references

Sanghoon Jheon

6

object named as

Sanghoon Jheon

0 references

Choon-Taek Lee

8

object named as

Choon-Taek Lee

0 references

author name string

An Na Seo

1

0 references

Yan Jin

2

0 references

Hee Jin Lee

3

0 references

Ping-Li Sun

4

0 references

Hyojin Kim

5

0 references

Jin-Haeng Chung

Personalized therapy on the horizon for squamous cell carcinoma of the lung.

9

0 references

language of work or name

1 reference

November 2014

0 references

published in

Virchows Archiv

0 references

volume

465

0 references

issue

5

0 references

page(s)

547-58

0 references

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1634-2

Fibroblast growth factor receptor 1 gene amplification is associated with poor survival and cigarette smoking dosage in patients with resected squamous cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1634-2

FGFR1 expression and gene copy numbers in human lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1634-2

Frequency of fibroblast growth factor receptor 1 gene amplification in oral tongue squamous cell carcinomas and associations with clinical features and patient outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1634-2

Inhibitor-sensitive FGFR1 amplification in human non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1634-2

Gene amplification profiling of esophageal squamous cell carcinomas by DNA array CGH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1634-2

FGFR-1 amplification in metastatic lymph-nodal and haematogenous lobular breast carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1634-2

FGFR1 is amplified during the progression of in situ to invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1634-2

FGFR1 is essential for prostate cancer progression and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1634-2

FGFR1 over-expression in primary rhabdomyosarcoma tumors is associated with hypomethylation of a 5' CpG island and abnormal expression of the AKT1, NOG, and BMP4 genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1634-2

Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1634-2

A therapeutic target for smoking-associated lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1634-2

Translating the therapeutic potential of AZD4547 in FGFR1-amplified non-small cell lung cancer through the use of patient-derived tumor xenograft models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1634-2

Ponatinib (AP24534), a multitargeted pan-FGFR inhibitor with activity in multiple FGFR-amplified or mutated cancer models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1634-2

FGFR1 amplification in squamous cell carcinoma of the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1634-2

International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1634-2

Epidermal growth factor receptor mutation and p53 overexpression during the multistage progression of small adenocarcinoma of the lung.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1634-2

Alteration of the E-Cadherin/β-Catenin Complex Is an Independent Poor Prognostic Factor in Lung Adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1634-2

Adding to the mix: fibroblast growth factor and platelet-derived growth factor receptor pathways as targets in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1634-2

Determining the profiles and parameters for gene amplification testing of growth factor receptors in lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1634-2

Tissue microarrays in clinical oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1634-2

Definition of a fluorescence in-situ hybridization score identifies high- and low-level FGFR1 amplification types in squamous cell lung cancer.

21 January 2018

1 reference

12 December 2020

Co-expression of aFGF and FGFR-1 is predictive of a poor prognosis in patients with esophageal squamous cell carcinoma.

1 reference

12 December 2020

Tumor angiogenesis in pulmonary adenocarcinomas: relationship with basic fibroblast growth factor, its receptor, and survival

1 reference

12 December 2020

FOXO1-FGFR1 fusion and amplification in a solid variant of alveolar rhabdomyosarcoma

1 reference

12 December 2020

Tissue microarrays are an effective quality assurance tool for diagnostic immunohistochemistry

1 reference

12 December 2020

A genomics-based classification of human lung tumors

1 reference

12 December 2020

Increased FGFR1 copy number in lung squamous cell carcinomas.

1 reference

12 December 2020

Fibroblast growth factor receptor 1 (FGFR1) copy number is an independent prognostic factor in non-small cell lung cancer

1 reference

12 December 2020